Gotham Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.8M | Buy |
|
|||||
|
2025
Q1 | $3.92M | Buy |
|
|||||
|
2024
Q4 | $2.57M | Sell |
|
|||||
|
2024
Q3 | $4.83M | Buy |
|
|||||
|
2024
Q2 | $3.22M | Buy |
|
|||||
|
2024
Q1 | $306K | Sell |
|
|||||
|
2023
Q4 | $2.07M | Buy |
|
|||||
|
2023
Q3 | $546K | Sell |
|
|||||
|
2023
Q2 | $733K | Sell |
|
|||||
|
2023
Q1 | $1.02M | Buy |
|
|||||
|
2022
Q4 | $805K | Buy |
|
|||||
|
2022
Q3 | $677K | Buy |
|
|||||
|
2022
Q2 | $453K | Buy |
|
|||||
|
2022
Q1 | $212K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $486K | Buy |
|
|||||
|
2019
Q4 | $336K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $294K | Sell |
|
|||||
|
2017
Q2 | $772K | Buy |
|